Ahmad Haidar, PhD

McGill University Health Centre/Research Institute of the McGill University Health Centre

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers

PubMed author-name match

Trials

Studies that name Ahmad Haidar, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:46 UTC. Open this list on ClinicalTrials.gov

Ph2/Ph3
NCT07284511 · A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
McGill University Health Centre/Research Institute of the McGill University Health Centre · recruiting · Type 1 Diabetes, Type 1 Diabetes Mellitus, T1D · study director
N/A
NCT05041621 · A Learning Algorithm for MDI Individuals With Type 1 Diabetes to Adjust Recommendations for High Fat Meals and Exercise Management
McGill University · completed · Type 1 Diabetes · study chair
Ph1
NCT04450563 · Low Dose Empagliflozin in Adults With Type 1 Diabetes on Closed Loop Insulin System
McGill University · completed · Type 1 Diabetes · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

PubMed returned no clinical-trial papers for this author name.